One could suggest this company is a sound business model.
$3,6000,000 in revenue
$7,000,000 cash
443m shares
227m shares held by the top twenty.
A global company with low overheads, repeat sales, contracts in place plus an FDA approval pending along with a 20-year patent.
Each to their own - but I like the numbers.
Ann: Appendix 4C - quarterly, page-14
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.81M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 68512 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 117920 | 1 |
View Market Depth
| Last trade - 10.19am 02/10/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable